Oriental Aromatics

NSE: OALBSE: 500078
Compare with peers
₹ 618.45▼ 7.25 (−1.16%)28 Oct, 03:29 pm IST
Market cap
₹ 1,939 Cr.
P/E
364.1x
P/B
2.98x
52-week range
228 – 645
ROE
1%
ROCE
4%
Dividend yield
0.1%
Debt / equity
0.61
Sector
Chemicals & Petrochemicals
Industry
Specialty Chemicals
Listed on
NSE, BSE

About

Oriental Aromatics Ltd is an India-based company, which is an integrated manufacturer of flavors, fragrance as well as specialty aroma chemicals. The Company operates through Fine Chemicals segment. Its products include fragrance, flavor, aroma chemicals, and camphor. The Company is a supplier of fine fragrance and perfume raw materials. It manufactures synthetic camphor, which can be utilized in several different ways. Its customers are located in North America, Europe and the Middle East.

Quick check

The five things to look at first. Open one for more.

Compared with its industry

Specialty Chemicals: 130 companies →

Oriental Aromatics against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.

  • Valuation (P/E)364.1 against a typical 26.3: pricier than most peers (1st = cheapest).126th of 129
  • Sales growth+15.2% against a typical +25.9% from a year earlier.83rd of 112
  • Profit growth+402% against a typical +42.4% from a year earlier.9th of 102
  • Share price, 3 months+55.2% against a typical −5.8%.5th of 118
  • Size₹ 1,938.7 Cr. market value against a typical ₹ 359.6 Cr. (1st = largest).34th of 126

Credit ratings

Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates

Adequate safety, with caution

Rated A- by ICRA
A-
DefaultRiskyModerateSafeVery safe
  • ICRA expects things to get worse (negative outlook).
AgencyCurrent ratingOutlookAs of
ICRA[ICRA]A-Negative23 Feb 2026
Credit rating actions
RatingDetails
23 Feb 2026
▼ Outlook cut
[ICRA]A-
Outlook Stable → Negative
—ICRA₹ 393.33 Cr.
15 Oct 2025
Reaffirmed
[ICRA]A- /[ICRA]A2+—ICRA₹ 393.33 Cr.

Board meetings

Results dates and other board meetings. Full calendar

Details
30 Jul 2026Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2026
20 May 2026Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2026 and dividend
12 Feb 2026Financial ResultsTo consider and approve the financial results for the period ended December 31, 2025
10 Nov 2025Financial ResultsTo consider and approve the financial results for the period ended September 30, 2025
8 Aug 2025Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2025
27 May 2025Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2025 and dividend

Share price

1Y change +71.06%
Volume (shares)Price (₹)
Close price

Financials

Consolidated figures in ₹ crore.

Quarterly results
₹ Cr.Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales227197216216237223253226271252282260
Expenses216183196194208200234207254238263240
Operating Profit111421222923191817131920
OPM %4.9%7.2%9.7%10.3%12.1%10.1%7.6%8%6.4%5.3%6.9%7.6%
Other Income322220003241
Interest5734669810998
Depreciation555556788888
Profit before tax3414151910433−275
Tax %29.2%41.2%28.3%26.1%23.1%27.7%60.9%80.5%73.1%4.4%45.7%52.4%
Net Profit231011157111−243
EPS in Rs0.720.783.013.264.392.120.420.150.22−0.571.190.75

Growth and returns

Compounded yearly rates over each period.

Compounded Sales Growth
10 Years
—
5 Years
8%
3 Years
6%
TTM
14%
Compounded Profit Growth
10 Years
—
5 Years
−50%
3 Years
−45%
TTM
−78%
Stock Price CAGR
10 Years
9%
5 Years
−16%
3 Years
−5%
TTM
—
Return on Equity
10 Years
8%
5 Years
4%
3 Years
2%
TTM
—

Shareholding

Latest: Jun 2026.

Promoters
74.17%
0 pts in a year
FIIs
0.02%
0 pts in a year
DIIs
0%
0 pts in a year
Public
25.81%
−0.01 pts in a year

P/E and EPS over time

Daily P/E and trailing 12-month EPS. EPS updates with each result.

P/E 364.1xEPS (12 months) ₹ 1.58Median P/E 36.2x
P/E (times)EPS (₹)

Peers

Listed companies in the same business.

Peer comparison
Oriental Aromatics₹ 618.45₹ 1,939 Cr.364.1x3x1%—
Hindustan Unilever₹ 1,820.00₹ 4,27,626 Cr.48.3x10.3x21.5%16.1%
Godrej Consumer Products₹ 851.50₹ 87,134 Cr.54.2x8.7x15.1%12.3%
Marico₹ 764.10₹ 99,347 Cr.62.2x26x43.1%13.3%
Dabur India₹ 366.00₹ 64,927 Cr.40x6.6x17.1%14.2%
Cupid₹ 306.50₹ 41,214 Cr.271.9x64.1x27.3%30.3%

Management

Dharmil A. Bodani
Executive Chairman of the Board, Managing Director
Parag K. Satoskar
Chief Executive Officer
Girish Khandelwal
Chief Financial Officer
Anita Parag Satoskar
Chief Technology Officer
Kiranpreet Gill
Compliance Officer, Company Secretary
Shyamal A. Bodani
Executive Director
Satish Kumar Ray
Executive Director - Operations

Prices are delayed and for information only. Nothing on this page is investment advice.